Shweta Urva
12PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Sep 05, 2025
Reply to "Revisiting Tirzepatide's Body Composition Model: Underestimated Fat-Free Mass Loss and Clinical Implications".Emmanuel Chigutsa, Lucy Her, Xiaosu Ma
|Jun 25, 2025
A Pharmacometric Method for Quantitative Determination of Improvement in Body Composition and Characterization of the Exposure-Response Relationship during Treatment of Obesity with Tirzepatide.Emmanuel Chigutsa, Lucy Her, Xiaosu Ma
|Jan 06, 2025
Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis.Kieren J Mather, Andrea Mari, Govinda Weerakkody
|Aug 27, 2024
A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy.Filip K Knop, Shweta Urva, Mallikarjuna Rettiganti
|Jul 08, 2024
Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper.Aarti Sawant-Basak, Shweta Urva, Jatinder Kaur Mukker
|Feb 26, 2024
Model-based simulation of glycaemic effect and body weight loss when switching from semaglutide or dulaglutide to once weekly tirzepatide.Shweta Urva, Joshua A Levine, Karen Schneck
Pageof 2
Frequent Collaborators
4 joint publications
Axel Haupt
4 joint publications
Karen Schneck
2 joint publications
Tamer Coskun
2 joint publications
Kieren J Mather
1 joint publications
Michael A Nauck
1 joint publications
Tomonori Oura
1 joint publications
Kenji Ohwaki
1 joint publications
Andrea Hemmingway
1 joint publications
Joshua A Levine
1 joint publications
Cheng Cai Tang
